4004-75-5

Basic information

• Product Name: N-(2-{[(4-methylphenyl)sulfonyl]amino}ethyl)-4-({[3-nitro-5-(trifluoromethyl)phenyl]carbonyl}amino)piperidine-4-carboxamide
• CAS NO: 4004-75-5
• Molecular Formula: C₂₃H₂₆F₃N₅O₆S
• Molecular Weight: 557.5426
• Mol File: 4004-75-5.mol
• Article Data: 3

Chemical Properties

• Density: 1.46g/cm³
• Refractive Index: 1.603
• CAS DataBase Reference: N-(2-{[(4-methylphenyl)sulfonyl]amino}ethyl)-4-({[3-nitro-5-(trifluoromethyl)phenyl]carbonyl}amino)piperidine-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-{[(4-methylphenyl)sulfonyl]amino}ethyl)-4-({[3-nitro-5-(trifluoromethyl)phenyl]carbonyl}amino)piperidine-4-carboxamide(4004-75-5)
• EPA Substance Registry System: N-(2-{[(4-methylphenyl)sulfonyl]amino}ethyl)-4-({[3-nitro-5-(trifluoromethyl)phenyl]carbonyl}amino)piperidine-4-carboxamide(4004-75-5)

Safety Data

• Hazardous Substances Data: 4004-75-5(Hazardous Substances Data)

Upstream product

• 516-41-6 11β,17α,21-trihydroxy-5α-pregnane-3,20-dione 
• 4004-68-6 RU 18748 
• 131061-53-5 1-[(3R,5S,8S,9S,10S,11S,13S,14S,17R)-3-(tert-Butyl-dimethyl-silanyloxy)-11,17-dihydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl]-2-(tetrahydro-pyran-2-yloxy)-ethanone 
• 56736-68-6 2-((8S,9S,10R,11S,13S,14S,17R)-3-ethoxy-11,17-dihydroxy-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate 
• 131061-49-9 5α-dihydrocortisol 21-tetrahydropyranyl ether 
• 131061-54-6 allotetrahydrocortisol 3-tert-butyldimethylsilyl ether 
• 131061-50-2 allotetrahydrocortisol 21-tetrahydropyranyl ether 
• 50-03-3 hydrocortisone acetate 
• 131061-55-7 21-acetoxy-3α,11β,17α-trihydroxy-5α-pregnan-20-one 3-tert-butyldimethylsilyl ether 
• 110331-27-6 21-bromo-3α,11α,17-trihydroxy-5β-pregnan-20-one 
• 127-08-2 potassium acetate 

Downstream Products

• 30954-21-3 allotetrahydrocortisol 3-glucuronide 
• 565-88-8 5α-androst-2-ene-11,17-dione 
• 57-61-4 (3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-tetradecahydro-2H-cyclopenta[a]phenanthren-17(14H)-one 

Relevant articles and documents

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Described herein are neuroactive steroids of the Formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof; wherein R1a and R1b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.

Chemical conversion of corticosteroids to 3α,5α-tetrahydro derivatives. Synthesis of allotetrahydrocortisol glucuronides and allotetrahydrocortisone glucuronides

-